Latest news with #RosuvasF20
Indian Express
10 hours ago
- Health
- Indian Express
Delhi drugs control department cracks down on sale of fake cholesterol medicines
The Delhi drugs control department recently uncovered a multi-level distribution network involved in the sale and circulation of spurious Rosuvas F 20 tablets, a prescription drug used to manage cholesterol and triglyceride levels, officials said on Friday. The action followed a complaint from Sun Pharmaceutical Industries Ltd, which reported that fake versions of its Rosuvas F 20 tablets were being sold by a retail outlet in central Delhi. The complaint mentioned a multi-level supply chain involving multiple wholesalers and distributors across the city. Rosuvas F 20 is a fixed-dose combination drug containing Rosuvastatin (20 mg) and Fenofibrate (160 mg). It is commonly prescribed to patients who require medication to manage high cholesterol and triglyceride levels, especially when lifestyle changes alone are not sufficient. The drug plays a vital role in preventing serious cardiovascular conditions such as heart attacks and strokes. Drugs control department officials said Rosuvas F 20 tablets were a fast-moving drug, and on June 14 and 15, 1,800 spurious tablets worth Rs 88,000 were seized from two locations in Okhla and Bhagirath Palace. 'On June 14, we first received a complaint from Rajinder Nagar, but no stock was found. A link was established in Okhla and Bhagirath Palace, where raids were conducted,' an official said. Officials noted irregularities and a suspicious absence of genuine stock at several distribution points, which ultimately led them to a firm located in the Okhla Industrial Area. 'Visual inspection and comparison with authentic samples suggested that the seized products were spurious — their appearance and packaging did not match those of the legitimate manufacturer,' said an official. Here, additional suspect stock of Rosuvas F 20 was found. Legal samples were collected from Bhagirath Palace, Chandni Chowk—one of Delhi's busiest medicine markets—and sent to a government laboratory for quality testing, while manufacturer verification is also underway, officials revealed. The department has secured custody permission for the seized drugs through the Delhi High Court. 'We are now coordinating with authorities in other states to trace the full supply chain behind the fake medication,' the official said.
The Hindu
19-06-2025
- The Hindu
Counterfeit cholesterol drugs worth ₹3 lakh seized in raids at Koti
Officials from the Drugs Control Administration (DCA) carried out raids on multiple pharmaceutical dealers in Koti, Hyderabad and uncovered counterfeit stocks of the cholesterol-lowering medications Rosuvas F 20 and Rosuvas F 10. These drugs are prescribed to lower cholesterol and triglyceride levels and prevent heart-related ailments. The spurious drugs were being circulated in the open market under the guise of legitimate products manufactured by Sun Pharmaceutical Industries Limited. During the inspections on Thursday, DCA's special enforcement team raided two outlets, Ganga Pharma Distributors and Sri Nandini Pharma, and seized fake batches of the medicine, both falsely labelled as being manufactured in December 2024 and set to expire in May 2027. The counterfeit packaging claimed Sun Pharma's Sikkim unit as the manufacturing site, said a release. The estimated value of the seized counterfeit medicines is ₹3 lakh. Upon verification, Sun Pharmaceutical Industries Limited confirmed to the authorities that the seized stocks were not genuine and had not been produced by their company. Officials stated that a detailed investigation is underway to trace the entire supply chain of the counterfeit products and that legal action will be initiated against all those found responsible.
